North America In Vitro Diagnostics (IVD) Market 2022-2031 by Product (Instruments & Devices, Reagents & Kits, Software & Services), Technology (Clinical Chemistry, Molecular Diagnostics, Immuno Diagnostics), Sample Type (Blood, Mucus, Urine), Application (Infectious Diseases, Diabetes, Cancer/Oncology), End User (Diagnostic Labs, Hospitals and Clinics, Homecare, POC), and Country: Trend Forecast and Growth Opportunity
- Report ID: 43710
- Date: Sep, 2022
- Pages: 131
- Category: Healthcare & Pharmaceuticals
North America in vitro diagnostics (IVD) market is projected to grow by 5.6% annually in the forecast period and reach $ 54,000.3 million by 2031, driven by the increasing prevalence of chronic diseases along with the growing geriatric population, burgeoning demand for automation in diagnostics, the rising development of condition-specific treatment and booming awareness regarding personalized medicines, emergence of minimally invasive and non-invasive diagnostics tools & techniques, the rising healthcare expenditure, and rise in the demand for POC testing.
Highlighted with 25 tables and 60 figures, this 131-page report “North America In Vitro Diagnostics (IVD) Market 2021-2031 by Product (Instruments & Devices, Reagents & Kits, Software & Services), Technology (Clinical Chemistry, Molecular Diagnostics, Immuno Diagnostics), Sample Type (Blood, Mucus, Urine), Application (Infectious Diseases, Diabetes, Cancer/Oncology), End User (Diagnostic Labs, Hospitals and Clinics, Homecare, POC), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire North America in vitro diagnostics (IVD) market and all its sub-segments through extensively detailed classifications.
Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify North America in vitro diagnostics (IVD) market in every aspect of the classification from perspectives of Product, Technology, Sample Type, Application, End User, and Country.
Based on Product, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Instruments & Devices
o Disposable IVD Devices
o Reusable IVD Devices
• Reagents & Kits
• Software & Services
Based on Technology, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Clinical Chemistry
• Molecular Diagnostics
• Immuno Diagnostics
• Hematology
• Tissue Diagnostics
• Microbiology
• Coagulation and Hemostasis
• Urinalysis
• Other Technologies
By Sample Type, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Blood
• Mucus
• Urine
• Other Sample Types
By Application, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Infectious Diseases
• Diabetes
• Cancer/Oncology
• Cardiology
• Autoimmune Disease
• Nephrology
• Drug Testing
• HIV/AIDS
• Other Applications
By End User, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Diagnostic Laboratories
• Hospitals and Clinics
• Homecare Settings
• Point-of-Care (POC) Settings
• Other End Users
Geographically, the following national/local markets are fully investigated:
• U.S.
• Canada
• Mexico
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Product, Application and End User over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Abbott Laboratories, Inc.
Agilent Technologies, Inc.
Arkray Inc.
Becton, Dickinson and Company
Biomerieux SA
Bio-Rad Laboratories Inc.
Danaher Corporation
DiaSorin SpA (Luminex Corporation)
Epic Systems Corporation
F. Hoffmann-La Roche Ltd.
Genpact Limited
Grifols SA
IBM Corporation
Mckesson Corporation
Ortho Clinical Diagnostics Inc.
Qiagen NV
Quest Diagnostics Inc.
Quidel Corporation
Roche Diagnostics
Siemens Healthineers
Sysmex Corporation
Thermo Fisher Scientific Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Reasons to Purchase
• The most thorough study on this industry, encompassing 12 regions, will provide you a genuinely worldwide view.
• Recognize the impact of the coronavirus on the market and how it is expected to change and expand as the virus's effects fade.
• Develop national and regional plans based on research and analysis conducted locally.
• Find investment opportunities in growing segments.
• Outperform rivals by using forecast data as well as market drivers and trends.
• Recognize consumer needs based on recent market research results.
• Performance comparisons with significant rivals.
• For better planning, take use of the connections between important data sets.
• Appropriate for using high-quality, trustworthy data and analysis to support your internal and external presentations.
1 Introduction 7
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 8
1.2 Research Methodology 11
1.2.1 Overview of Market Research Methodology 11
1.2.2 Market Assumption 12
1.2.3 Secondary Data 12
1.2.4 Primary Data 12
1.2.5 Data Filtration and Model Design 13
1.2.6 Market Size/Share Estimation 14
1.2.7 Research Limitations 15
1.3 Executive Summary 16
2 Market Overview and Dynamics 19
2.1 Market Size and Forecast 19
2.1.1 Impact of COVID-19 on World Economy 20
2.1.2 Impact of COVID-19 on the Market 24
2.2 Major Growth Drivers 26
2.3 Market Restraints and Challenges 32
2.4 Emerging Opportunities and Market Trends 35
2.5 Porter’s Fiver Forces Analysis 39
3 Segmentation of North America Market by Product 43
3.1 Market Overview by Product 43
3.2 Instruments & Devices 45
3.2.1 Disposable IVD Devices 46
3.2.2 Reusable IVD Devices 47
3.3 Reagents & Kits 48
3.4 Software & Services 49
4 Segmentation of North America Market by Technology 50
4.1 Market Overview by Technology 50
4.2 Clinical Chemistry 52
4.3 Molecular Diagnostics 53
4.4 Immuno Diagnostics 54
4.5 Hematology 55
4.6 Tissue Diagnostics 56
4.7 Microbiology 57
4.8 Coagulation and Hemostasis 58
4.9 Urinalysis 59
4.10 Other Technologies 60
5 Segmentation of North America Market by Sample Type 61
5.1 Market Overview by Sample Type 61
5.2 Blood 63
5.3 Mucus 64
5.4 Urine 65
5.5 Other Sample Types 66
6 Segmentation of North America Market by Application 67
6.1 Market Overview by Application 67
6.2 Infectious Diseases 69
6.3 Diabetes 79
6.4 Cancer/Oncology 80
6.5 Cardiology 81
6.6 Autoimmune Disease 82
6.7 Nephrology 83
6.8 Drug Testing 84
6.9 HIV/AIDS 85
6.10 Other Applications 86
7 Segmentation of North America Market by End User 87
7.1 Market Overview by End User 87
7.2 Diagnostic Laboratories 89
7.3 Hospitals and Clinics 90
7.4 Homecare Settings 91
7.5 Point-of-Care (POC) Settings 92
7.6 Other End Users 93
8 North America Market 2021-2031 by Country 94
8.1 Overview of North America Market 94
8.2 U.S. 97
8.3 Canada 100
8.4 Mexico 102
9 Competitive Landscape 104
9.1 Overview of Key Vendors 104
9.2 New Product Launch, Partnership, Investment, and M&A 107
9.3 Company Profiles 108
Abbott Laboratories, Inc. 108
Agilent Technologies, Inc. 110
Arkray Inc. 111
Becton, Dickinson and Company 112
Biomerieux SA 113
Bio-Rad Laboratories Inc. 114
Danaher Corporation 115
DiaSorin SpA (Luminex Corporation) 116
Epic Systems Corporation 117
F. Hoffmann-La Roche Ltd. 118
Genpact Limited 119
Grifols SA 120
IBM Corporation 121
Mckesson Corporation 122
Ortho Clinical Diagnostics Inc. 123
Qiagen NV 124
Quest Diagnostics Inc. 125
Quidel Corporation 126
Roche Diagnostics 127
Siemens Healthineers 128
Sysmex Corporation 129
Thermo Fisher Scientific Inc. 130
RELATED REPORTS 131
List of Tables
List of Tables:
Table 1. Snapshot of North America In Vitro Diagnostics Market in Balanced Perspective, 2021-2031 17
Table 2. World Economic Outlook, 2021-2031 21
Table 3. World Economic Outlook, 2021-2023 22
Table 4. World Health Spending by Region, $ bn, 2013-2020 31
Table 5. Main Product Trends and Market Opportunities in North America In Vitro Diagnostics Market 35
Table 6. North America In Vitro Diagnostics Market by Product, 2021-2031, $ mn 43
Table 7. North America In Vitro Diagnostics Market: Instruments & Devices by Type, 2021-2031, $ mn 45
Table 8. North America In Vitro Diagnostics Market by Technology, 2021-2031, $ mn 50
Table 9. North America In Vitro Diagnostics Market by Sample Type, 2021-2031, $ mn 61
Table 10. North America In Vitro Diagnostics Market by Application, 2021-2031, $ mn 67
Table 11. Commercially Available COVID-19 Diagnostic Tests Approved in 2021-2022 70
Table 12. North America In Vitro Diagnostics Market by End User, 2021-2031, $ mn 87
Table 13. North America In Vitro Diagnostics Market by Country, 2021-2031, $ mn 95
Table 14. U.S. In Vitro Diagnostics Market by Product, 2021-2031, $ mn 99
Table 15. U.S. In Vitro Diagnostics Market by Sample Application, 2021-2031, $ mn 99
Table 16. U.S. In Vitro Diagnostics Market by End User, 2021-2031, $ mn 99
Table 17. Canada In Vitro Diagnostics Market by Product, 2021-2031, $ mn 101
Table 18. Canada In Vitro Diagnostics Market by Sample Application, 2021-2031, $ mn 101
Table 19. Canada In Vitro Diagnostics Market by End User, 2021-2031, $ mn 101
Table 20. Mexico In Vitro Diagnostics Market by Product, 2021-2031, $ mn 103
Table 21. Mexico In Vitro Diagnostics Market by Sample Application, 2021-2031, $ mn 103
Table 22. Mexico In Vitro Diagnostics Market by End User, 2021-2031, $ mn 103
Table 23. Abbott Laboratories, Inc.: Company Snapshot 108
Table 24. Abbott Laboratories, Inc.: Business Segmentation 109
Table 25. Abbott Laboratories, Inc.: Product Portfolio 109
List of Figures
List of Figures:
Figure 1. Research Method Flow Chart 11
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 14
Figure 3. North America Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031 16
Figure 4. North America In Vitro Diagnostics Market, 2021-2031, $ mn 19
Figure 5. Impact of COVID-19 on Business 24
Figure 6. Primary Drivers and Impact Factors of North America In Vitro Diagnostics Market 26
Figure 7. Leading Causes of Death in the World, 2000 and 2019, million 29
Figure 8. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 30
Figure 9. World Population 65 and Over, % of Total Population, 1950-2060 30
Figure 10. Primary Restraints and Impact Factors of North America In Vitro Diagnostics Market 32
Figure 11. Investment Opportunity Analysis 36
Figure 12. Porter’s Fiver Forces Analysis of North America In Vitro Diagnostics Market 39
Figure 13. Breakdown of North America In Vitro Diagnostics Market by Product, 2021-2031, % of Revenue 44
Figure 14. North America Addressable Market Cap in 2022-2031 by Product, Value ($ mn) and Share (%) 44
Figure 15. North America In Vitro Diagnostics Market by Product: Instruments & Devices, 2021-2031, $ mn 45
Figure 16. North America In Vitro Diagnostics Market by Instruments & Devices: Disposable IVD Devices, 2021-2031, $ mn 46
Figure 17. North America In Vitro Diagnostics Market by Instruments & Devices: Reusable IVD Devices, 2021-2031, $ mn 47
Figure 18. North America In Vitro Diagnostics Market by Product: Reagents & Kits, 2021-2031, $ mn 48
Figure 19. North America In Vitro Diagnostics Market by Product: Software & Services, 2021-2031, $ mn 49
Figure 20. Breakdown of North America In Vitro Diagnostics Market by Technology, 2021-2031, % of Sales Revenue 51
Figure 21. North America Addressable Market Cap in 2022-2031 by Technology, Value ($ mn) and Share (%) 51
Figure 22. North America In Vitro Diagnostics Market by Technology: Clinical Chemistry, 2021-2031, $ mn 52
Figure 23. North America In Vitro Diagnostics Market by Technology: Molecular Diagnostics, 2021-2031, $ mn 53
Figure 24. North America In Vitro Diagnostics Market by Technology: Immuno Diagnostics, 2021-2031, $ mn 54
Figure 25. North America In Vitro Diagnostics Market by Technology: Hematology, 2021-2031, $ mn 55
Figure 26. North America In Vitro Diagnostics Market by Technology: Tissue Diagnostics, 2021-2031, $ mn 56
Figure 27. North America In Vitro Diagnostics Market by Technology: Microbiology, 2021-2031, $ mn 57
Figure 28. North America In Vitro Diagnostics Market by Technology: Coagulation and Hemostasis, 2021-2031, $ mn 58
Figure 29. North America In Vitro Diagnostics Market by Technology: Urinalysis, 2021-2031, $ mn 59
Figure 30. North America In Vitro Diagnostics Market by Technology: Other Technologies, 2021-2031, $ mn 60
Figure 31. Breakdown of North America In Vitro Diagnostics Market by Sample Type, 2021-2031, % of Sales Revenue 62
Figure 32. North America Addressable Market Cap in 2022-2031 by Sample Type, Value ($ mn) and Share (%) 62
Figure 33. North America In Vitro Diagnostics Market by Sample Type: Blood, 2021-2031, $ mn 63
Figure 34. North America In Vitro Diagnostics Market by Sample Type: Mucus, 2021-2031, $ mn 64
Figure 35. North America In Vitro Diagnostics Market by Sample Type: Urine, 2021-2031, $ mn 65
Figure 36. North America In Vitro Diagnostics Market by Sample Type: Other Sample Types, 2021-2031, $ mn 66
Figure 37. Breakdown of North America In Vitro Diagnostics Market by Application, 2021-2031, % of Revenue 68
Figure 38. North America Addressable Market Cap in 2022-2031 by Application, Value ($ mn) and Share (%) 68
Figure 39. North America In Vitro Diagnostics Market by Application: Infectious Diseases, 2021-2031, $ mn 69
Figure 40. North America In Vitro Diagnostics Market by Application: Diabetes, 2021-2031, $ mn 79
Figure 41. North America In Vitro Diagnostics Market by Application: Cancer/Oncology, 2021-2031, $ mn 80
Figure 42. North America In Vitro Diagnostics Market by Application: Cardiology, 2021-2031, $ mn 81
Figure 43. North America In Vitro Diagnostics Market by Application: Autoimmune Disease, 2021-2031, $ mn 82
Figure 44. North America In Vitro Diagnostics Market by Application: Nephrology, 2021-2031, $ mn 83
Figure 45. North America In Vitro Diagnostics Market by Application: Drug Testing, 2021-2031, $ mn 84
Figure 46. North America In Vitro Diagnostics Market by Application: HIV/AIDS, 2021-2031, $ mn 85
Figure 47. North America In Vitro Diagnostics Market by Application: Other Applications, 2021-2031, $ mn 86
Figure 48. Breakdown of North America In Vitro Diagnostics Market by End User, 2021-2031, % of Revenue 88
Figure 49. North America Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%) 88
Figure 50. North America In Vitro Diagnostics Market by End User: Diagnostic Laboratories, 2021-2031, $ mn 89
Figure 51. North America In Vitro Diagnostics Market by End User: Hospitals and Clinics, 2021-2031, $ mn 90
Figure 52. North America In Vitro Diagnostics Market by End User: Homecare Settings, 2021-2031, $ mn 91
Figure 53. North America In Vitro Diagnostics Market by End User: Point-of-Care (POC) Settings, 2021-2031, $ mn 92
Figure 54. North America In Vitro Diagnostics Market by End User: Other End Users, 2021-2031, $ mn 93
Figure 55. Breakdown of North America In Vitro Diagnostics Market by Country, 2021 and 2031, % of Revenue 95
Figure 56. Contribution to North America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 96
Figure 57. U.S. In Vitro Diagnostics Market, 2021-2031, $ mn 98
Figure 58. Canada In Vitro Diagnostics Market, 2021-2031, $ mn 100
Figure 59. In Vitro Diagnostics Market in Mexico, 2021-2031, $ mn 102
Figure 60. Growth Stage of North America In Vitro Diagnostics Industry over the Forecast Period 104
Research methodology is mainly referring to the practical how of any offered piece of research. More specifically, it’s all about how a researcher systematically designs a study in order to assure extremely valid as well as reliable results that ultimately address the targets and objectives of the research.
In any formal research including academic journal, article, dissertation and so on, there will be a special section on a research methodology that mainly describes what, by whom, how to gather as well as how to evaluate the data are provided.
This research methodology has been segmented into following types:
Primary Research:
It is said to be original information that the researchers collect for the crucial purposes of answering the research questions of readers with the help of surveys, observations and experiments.
Secondary Research:
The secondary research is the data that has already been collected by various other researchers in the form of government analysis or scientific studies.
Qualitative Research:
It is descriptive and subjective method irrespective of facts. Both observation and description are essential in this type of research methodology. Its main vision is to analyze knowledge, attitudes, behaviours as well as opinions of people related to the topic of any research. This method has been operated through grounded research, case study and actionable research.
Quantitative Research:
It contains several laboratory experiments, basic surveys, mathematical calculations, simulations and so on. The possible measurement, quantity or amount is considered to be a major factor in the quantitative research methodology.
Clients
